US Patent Issued to Paean Biotechnology on Sept. 2 for "Injection composition containing isolated mitochondria, and use thereof" (South Korean Inventors)

ALEXANDRIA, Va., Sept. 3 -- United States Patent no. 12,403,160, issued on Sept. 2, was assigned to Paean Biotechnology Inc. (Daejeon, South Korea).

"Injection composition containing isolated mitochondria, and use thereof" was invented by Young-Cheol Kang (Wonju-si, South Korea), Kyuboem Han (Daejeon, South Korea), Sang-Min Lim (Incheon, South Korea), Hahnsun Jung (Gunpo-si, South Korea), Hye Jeong Hwang (Cheongju-si, South Korea) and Junyoung Son (Seoul, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided is a composition for injection containing isolated mitochondria. More specifically, provided is a liquid composition for injection containing glycine, saccharide, buffer, and mitochondria, ...